Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study
JAK2(V617F)突变状态对原发性血小板增多症患者阿那格雷治疗反应的影响:一项观察性假设生成研究
期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S79576
Cascavilla, Nicola; De Stefano, Valerio; Pane, Fabrizio; Pancrazzi, Alessandro; Iurlo, Alessandra; Gobbi, Marco; Palandri, Francesca; Specchia, Giorgina; Liberati, A Marina; D'Adda, Mariella; Gaidano, Gianluca; Fjerza, Rajmonda; Achenbach, Heinrich; Smith, Jonathan; Wilde, Paul; Vannucchi, Alessandro M